Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of evolution of vaccination. We have Dr Srivastava and Dr Jaydeep Choudhury to lead the session.
It is well known to each one of us how the science of vaccine development has evolved starting from the invention of attenuated vaccines. We are also aware about the importance of vaccination for the children or neonates.
In this webinar, a more detailed discussion is provided on the development of 6-in-1 aP combination vaccine, its usage and its importance among the pediatric population.
The 6-in-1 aP combination vaccine is referred as DTaP/Hib/HepB/IPV, stands for 'Diphtheria, Tetanus, acellular Pertussis, Hib, Hepatitis B and Inactivated Polio Vaccine'. The advantage is one single vaccine can protect the child from the mentioned diseases and save the child from taking each of vaccines separately.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma
2.
Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL
3.
A Lot Can Be Said About You by Including Yourself in Photos.
4.
A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.
5.
Researchers discuss HER2-low and HER2-zero in breast cancer
1.
Seeing the Difference: Using Ultrasound to Distinguish Fibroadenoma from Cancer
2.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
3.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
4.
Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment
5.
Don't Ignore Your Vision Loss: What You Need to Know About Amaurosis Fugax
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation